Related Experiment Video
Updated: Sep 22, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Immunopathogenesis and Immunogenetic Variants in COVID-19
Pakorn Sagulkoo1,2, Kitiporn Plaimas3,4, Apichat Suratanee5,6
1Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok 10330, Thailand.
Insights
This study investigates immunogenetic variants, specifically NLRP3 and IL-18, in severe COVID-19 and cytokine storm development. Protein-protein interaction network analysis identified potential drug targets and predictive markers for severe disease outcomes.
Area of Science:
- Immunology
- Genetics
- Virology
Background:
- Despite vaccine availability, Coronavirus disease 2019 (COVID-19) continues to spread globally, leading to severe complications like acute respiratory distress syndrome and cytokine storms.
- Immunopathology and immunogenetics are crucial for understanding, diagnosing, and treating severe COVID-19 and its associated cytokine storm.
- While many immune-related genetic variants have been studied, the roles of NOD-like receptor protein 3 (NLRP3) and interleukin 18 (IL-18) in COVID-19 clinical outcomes remain underexplored.
Purpose of the Study:
- To review the current understanding of COVID-19 immunopathogenesis and immunogenetic factors contributing to severe disease and cytokine storms.
- To construct and analyze protein-protein interaction (PPI) networks focusing on NLRP3 and IL-18 variants in severe COVID-19.
- To identify potential drug targets and predictive biomarkers for severe COVID-19 and associated cytokine storms.
Main Methods:
- Literature review on COVID-19 immunopathogenesis and immunogenetics.
- Construction and analysis of protein-protein interaction (PPI) networks using enrichment and annotation analysis.
- Focus on NLRP3 and IL-18 variants and their association with severe COVID-19.
Main Results:
- PPI network and enrichment analyses identified key antiviral pathways, including Toll-Like-Receptor cascades, NOD-like receptor signaling, and interferon signaling.
- Significant involvement of interleukins (IL-1, IL-6, IL-12, IL-18) and tumor necrosis factor signaling in severe COVID-19 pathophysiology was predicted.
- Innate immune evasion by SARS-CoV-2 and the roles of MYD88 and MAVS in severe COVID-19 were highlighted.
Conclusions:
- The study predicts potential drug targets for preventing severe COVID-19 by modulating identified antiviral and inflammatory pathways.
- Genetic variants within the constructed PPI network may serve as predictors for severe COVID-19 outcomes.
- Targeted preventive treatments can be developed based on these predictive markers and identified therapeutic targets.
Abstract:
Coronavirus disease 2019 (COVID-19) continues to spread globally despite the discovery of vaccines. Many people die due to COVID-19 as a result of catastrophic consequences, such as acute respiratory distress syndrome, pulmonary embolism, and disseminated intravascular coagulation caused by a cytokine storm. Immunopathology and immunogenetic research may assist in diagnosing, predicting, and treating severe COVID-19 and the cytokine storm associated with COVID-19. This paper reviews the immunopathogenesis and immunogenetic variants that play a role in COVID-19. Although various immune-related genetic variants have been investigated in relation to severe COVID-19, the NOD-like receptor protein 3 (NLRP3) and interleukin 18 (IL-18) have not been assessed for their potential significance in the clinical outcome. Here, we a) summarize the current understanding of the immunogenetic etiology and pathophysiology of COVID-19 and the associated cytokine storm; and b) construct and analyze protein-protein interaction (PPI) networks (using enrichment and annotation analysis) based on the NLRP3 and IL18 variants and all genes, which were established in severe COVID-19. Our PPI network and enrichment analyses predict a) useful drug targets to prevent the onset of severe COVID-19, including key antiviral pathways such as Toll-Like-Receptor cascades, NOD-like receptor signaling, RIG-induction of interferon (IFN) α/β, and interleukin (IL)-1, IL-6, IL-12, IL-18, and tumor necrosis factor signaling; and b) SARS-CoV-2 innate immune evasion and the participation of MYD88 and MAVS in the pathophysiology of severe COVID-19. The PPI network genetic variants may be used to predict more severe COVID-19 outcomes, thereby opening the door for targeted preventive treatments.
More Related Videos
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Single Nucleotide Polymorphisms-SNPs
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...

